









Markets
/
Stocks
/
nasdaq-rvty
/

Revvity Inc

RVTY

87.120USD

-0.720-0.82%

Close 03/26, 16:00（ET）Quotes delayed by 15 min

9.92BMarket Cap

42.09P/E TTM



Revvity Inc

87.120

-0.720-0.82%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Revvity Inc

Currency: USD Updated: 2026-03-25

Key Insights

Revvity Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 39 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 118.63.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Revvity Inc's Score

Industry at a Glance

Industry Ranking

39 / 209

Overall Ranking

123 / 4547

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Revvity Inc Highlights

StrengthsRisks

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 12.14%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 12.14%.

Fairly Valued

The company’s latest PE is 42.44, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 117.55M shares, decreasing 7.48% quarter-over-quarter.

Held by Diamond Hill Capital

Star Investor Diamond Hill Capital holds 426.90K shares of this stock.

Analyst Rating

Based on 20 analysts

Buy

Current Rating

118.632

Target Price

+36.11%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-25

The current financial score of Revvity Inc is 7.56, ranking 65 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 772.06M, representing a year-over-year increase of 5.85%, while its net profit experienced a year-over-year increase of 3.93%.

Score

Industry at a Glance

Previous score

7.56

Change



Financials

6.67

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.06

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.19

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.63

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

8.26

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Revvity Inc's Company Valuation

Currency: USD Updated: 2026-03-25

The current valuation score of Revvity Inc is 6.96, ranking 136 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 42.44, which is 113.12% below the recent high of 90.45 and 67.34% above the recent low of 13.86.

Score

Industry at a Glance

Previous score

6.96

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 39/209

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-25

The current earnings forecast score of Revvity Inc is 7.20, ranking 145 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 110.00, with a high of 135.00 and a low of 85.00.

Score

Industry at a Glance

Previous score

7.20

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 20 analysts

Buy

Current Rating

118.632

Target Price

+35.64%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Revvity Inc

RVTY

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-25

The current price momentum score of Revvity Inc is 6.86, ranking 82 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 96.87 and the support level at 81.14, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.67

Change

0.19

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.691

Neutral

RSI(14)

38.309

Neutral

STOCH(KDJ)(9,3,3)

58.438

Neutral

ATR(14)

3.143

Low Volatility

CCI(14)

15.227

Neutral

Williams %R

61.132

Sell

TRIX(12,20)

-0.619

Sell

StochRSI(14)

73.545

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

87.104

Buy

MA10

86.563

Buy

MA20

89.934

Sell

MA50

99.129

Sell

MA100

98.698

Sell

MA200

95.419

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-25

The current institutional shareholding score of Revvity Inc is 10.00, ranking 1 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 103.68%, representing a quarter-over-quarter increase of 2.81%. The largest institutional shareholder is The Vanguard, holding a total of 13.13M shares, representing 11.75% of shares outstanding, with 3.38% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

T. Rowe Price Investment Management, Inc.

22.50M

-0.62%

The Vanguard Group, Inc.

Star Investors

13.47M

-4.02%

EdgePoint Investment Group Inc.

Star Investors

8.57M

+26.28%

T. Rowe Price Associates, Inc.

Star Investors

8.00M

+2.52%

Janus Henderson Investors

7.63M

+5.62%

BlackRock Institutional Trust Company, N.A.

6.04M

+3.95%

State Street Investment Management (US)

4.95M

-1.43%

Geode Capital Management, L.L.C.

2.96M

-0.56%

Dimensional Fund Advisors, L.P.

2.13M

+38.99%

Invesco Capital Management LLC

Star Investors

2.26M

+16.41%

Risk Assessment

Currency: USD Updated: 2026-03-25

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Revvity Inc is 7.44, ranking 41 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.14. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Revvity Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.